Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Saavedra

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-mazeAndrew Holmes, Jefferson W Kinney, Craige C Wrenn, et al.
The European Journal of Neuroscience|March 16, 2004
Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptorCraige C Wrenn, Jefferson W Kinney, Lisa K Marriott, et al.
Neuropeptides|June 10, 2005
Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout miceNathan R Rustay, Craige C Wrenn, Jefferson W Kinney, et al.
Nature Communications|May 31, 2020
TRPV4 disrupts mitochondrial transport and causes axonal degeneration via a CaMKII-dependent elevation of intracellular Ca<sup>2</sup>Brian M Woolums, Brett A McCray, Hyun Sung, et al.
Science Translational Medicine|May 22, 2024
Gain-of-function mutations of TRPV4 acting in endothelial cells drive blood-CNS barrier breakdown and motor neuron degeneration in miceJeremy M Sullivan, Anna M Bagnell, Jonathan Alevy, et al.
Science Advances|April 24, 2021
Three-dimensional microscale hanging drop arrays with geometric control for drug screening and live tissue imagingA Ganguli, A Mostafa, C Saavedra, et al.
Emerging Infectious Diseases|March 20, 2018
Seroprevalence of Chikungunya Virus after Its Emergence in BrazilJuarez P Dias, Maria da Conceição N Costa, Gubio Soares Campos, et al.
ESMO Open|September 10, 2024
Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trialM Vaz Batista, J M Pérez-García, P Cortez, et al.
The Journal of Clinical Investigation|February 18, 2020
Dominant mutations of the Notch ligand Jagged1 cause peripheral neuropathyJeremy M Sullivan, William W Motley, Janel O Johnson, et al.
ESMO Open|December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study GroupS P Gampenrieder, V Dezentjé, M Lambertini, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-mazeAndrew Holmes, Jefferson W Kinney, Craige C Wrenn, et al.
The European Journal of Neuroscience|March 16, 2004
Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptorCraige C Wrenn, Jefferson W Kinney, Lisa K Marriott, et al.
Neuropeptides|June 10, 2005
Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout miceNathan R Rustay, Craige C Wrenn, Jefferson W Kinney, et al.
Nature Communications|May 31, 2020
TRPV4 disrupts mitochondrial transport and causes axonal degeneration via a CaMKII-dependent elevation of intracellular Ca<sup>2</sup>Brian M Woolums, Brett A McCray, Hyun Sung, et al.
Science Translational Medicine|May 22, 2024
Gain-of-function mutations of TRPV4 acting in endothelial cells drive blood-CNS barrier breakdown and motor neuron degeneration in miceJeremy M Sullivan, Anna M Bagnell, Jonathan Alevy, et al.
Science Advances|April 24, 2021
Three-dimensional microscale hanging drop arrays with geometric control for drug screening and live tissue imagingA Ganguli, A Mostafa, C Saavedra, et al.
Emerging Infectious Diseases|March 20, 2018
Seroprevalence of Chikungunya Virus after Its Emergence in BrazilJuarez P Dias, Maria da Conceição N Costa, Gubio Soares Campos, et al.
ESMO Open|September 10, 2024
Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trialM Vaz Batista, J M Pérez-García, P Cortez, et al.
The Journal of Clinical Investigation|February 18, 2020
Dominant mutations of the Notch ligand Jagged1 cause peripheral neuropathyJeremy M Sullivan, William W Motley, Janel O Johnson, et al.
ESMO Open|December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study GroupS P Gampenrieder, V Dezentjé, M Lambertini, et al.
Pageof 11